| Lizenz: Allianz- bzw. Nationallizenz PDF - Veröffentlichte Version (424kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-361529
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.36152
Alternative Links zum Volltext:DOI
Zusammenfassung
Objectives: Several clinical studies have suggested the adipocytokine adiponectin is involved in the progression of rheumatoid arthritis (RA). From this point of view, adiponectin might present a new therapeutic target. However, as adiponectin also exerts beneficial effects in the human organism, a strategy that would allow its detrimental effects to be abolished while maintaining the positive ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik